Indomethacin and the response to bumetanide

Area of Science:

• Pharmacology
• Nephrology
• Drug Interactions

Background:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin can affect kidney function.
• Loop diuretics, such as bumetanide, are crucial for managing fluid balance.
• Understanding drug interactions is vital for safe and effective patient care.

Purpose of the Study:

• To investigate the impact of indomethacin on the natriuretic and diuretic response to bumetanide.
• To compare the effect of indomethacin on bumetanide with its known effect on furosemide.

Main Methods:

• Eight healthy subjects received indomethacin (100 mg) pretreatment.
• Bumetanide (1.0 mg) was administered, and cumulative 4-hour excretion of electrolytes (Na, Cl, K) was measured.
• Response was analyzed as the increment in fractional excretion over basal solute excretion.

Main Results:

• Indomethacin significantly reduced cumulative 4-hour sodium excretion in response to bumetanide (from 276 +/- 22.9 to 202 +/- 20.9 mEq; p < 0.003).
• Volume and chloride excretion changes mirrored sodium excretion.
• Potassium excretion remained unaffected by indomethacin pretreatment.
• The inhibitory effect of indomethacin on bumetanide response differed from its effect on furosemide response.

Conclusions:

• Indomethacin attenuates the natriuretic and diuretic effects of bumetanide in normal subjects.
• The mechanism underlying the differential effect of indomethacin on bumetanide versus furosemide remains unclear.
• Further research is needed to elucidate the clinical significance and underlying mechanisms of this drug interaction.